𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy

✍ Scribed by Aurélie Goyenvalle; Kay E Davies

Book ID
115028001
Publisher
BioMed Central
Year
2011
Tongue
English
Weight
230 KB
Volume
1
Category
Article
ISSN
2044-5040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Therapeutics in Duchenne muscular dystro
Therapeutics in Duchenne muscular dystrophy
✍ Strober, Jonathan B. 📂 Article 📅 2006 🏛 American Society for Experimental NeuroTherapeutic 🌐 English ⚖ 169 KB

Duchenne muscular dystrophy (DMD) is a fatal disorder affecting approximately 1 in 3500 live born males, characterized by progressive muscle weakness. Several different strategies are being investigated in developing a cure for this disorder. Until a cure is found, therapeutic and supportive care is

Cell based therapy for duchenne muscular
Cell based therapy for duchenne muscular dystrophy
✍ Andrea Farini; Paola Razini; Silvia Erratico; Yvan Torrente; Mirella Meregalli 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

## Abstract Mutations in the dystrophin gene cause an X‐linked genetic disorder: Duchenne muscular dystrophy (DMD). Stem cell therapy is an attractive method to treat DMD because a small number of cells are required to obtain a therapeutic effect. Here, we discussed about multiple types of myogenic